HLNE:NASDAQHamilton Lane Incorporated Analysis

Hamilton Lane (HLNE) is trading at $90.32, modestly above its 20‑day SMA of $88.69 but still below the 50‑day SMA of $95.29, indicating short‑term momentum is mixed while the longer‑term trend remains bearish. The RSI sits near 48, suggesting the stock is neither oversold nor overbought, and the MACD histogram is slightly positive, providing a marginal bullish signal despite the MACD line remaining below its signal. Volatility is elevated at nearly 49% over the past 30 days and beta exceeds 1.1, pointing to heightened price swings relative to the market. Fundamentally, the company posted a 2.2% revenue dip to $193.6 million in Q1 but beat profit expectations, delivering $1.49 per share versus consensus. Margins remain strong with a 32% profit margin and an ROE of 32%, while debt is modest (debt‑to‑equity ~24%) and cash balances roughly equal debt, underscoring a solid balance sheet. Analyst consensus is a “Buy” with a median price target of $141, implying roughly 50% upside from current levels.
However, the discounted cash‑flow model values HLNE at about $71.6, well below the market price, suggesting the stock may be overvalued on a pure intrinsic basis. The forward PE of 12.2 and current PE of 15.3 are slightly under the industry average of 16.8, which tempers the valuation concern. A dividend yield of 2.66% with a payout ratio near 36% appears sustainable given robust operating cash flow and free cash flow generation. The fear‑and‑greed index at 91.6 signals extreme market greed, which could amplify downside risk in a volatile environment. Geographically diversified AUM and a global client base reduce concentration risk, while regulatory exposure typical of asset managers remains moderate. Taken together, the blend of solid fundamentals, attractive dividend, and significant upside potential supports a longer‑term bullish stance.